+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kidney Disease Drug"

From
From
From
Polycystic Kidney Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Polycystic Kidney Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Diabetic Kidney Disease (DKD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Market Spotlight: Renal Disease - Product Thumbnail Image

Market Spotlight: Renal Disease

  • Report
  • March 2021
  • 52 Pages
  • Global
Global Polycystic Kidney Disease Drugs Market 2022-2026 - Product Thumbnail Image

Global Polycystic Kidney Disease Drugs Market 2022-2026

  • Report
  • July 2022
  • 120 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Kidney Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. These drugs are used to treat a variety of conditions, including chronic kidney disease, acute kidney injury, and end-stage renal disease. They can also be used to treat other conditions such as hypertension, diabetes, and anemia. These drugs are typically prescribed by a physician and can be taken orally or intravenously. They can also be administered through dialysis or other treatments. The Kidney Disease Drug market is highly competitive, with many companies offering a variety of products. These companies include major pharmaceutical companies, as well as smaller, specialized companies. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more